Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Lymphoma, Follicular 1 Endometrial Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 17 Rituximab 12 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Filgrastim 7 sargramostim 6 Vincristine 6 fludarabine phosphate 5 Radiotherapy 5 Doxorubicin 5 Cytarabine 5 Cisplatin 5 ibritumomab tiuxetan 4 Methylprednisolone 4 Melphalan 4 Etoposide 4 Dexamethasone 4 Cyclosporine 4 epratuzumab 3 Sensitivity and Specificity 3 Polymerase Chain Reaction 3 Mycophenolic Acid 3 Indium 3 Chlorambucil 3 Busulfan 3 Bendamustine Hydrochloride 3 Antilymphocyte Serum 3 Antigens, CD19 3 obinutuzumab 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, Follicular × fluciclovine F-18 × Clear all

NCT05479136 2022-10-27

DRARCH

St. Joseph's Hospital and Medical Center, Phoenix

Phase 3 Unknown

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡